The activation of plasminogen to plasmin by urokinase type plasminogen activator (uPA) is a critical step in a number of vascular processes leading resolution of fibrin thrombi, remodeling of vascular tissue matrix following injury, and sprouting and formation of new blood vessels. The initiative event of the uPA/plasmin cascade, the conversion of pro-uPA zymogen to active uPA is the limiting the therefore controlling reaction in the cascade. Once generated, plasmin can feed back and activate pro-uPA but the actual initiating event is undefined. A candidate for the initiating event is the intrinsic activity of pro-uPA itself which has been shown to be conditionally enhanced. A candidate for the initiating event is the intrinsic activity of pro-uPA itself which has been shown to be conditionally enhanced. Auto-activation is a cascade initiator until now has not been considered but will be in the present proposal. Direct control of the uPA/plasmin cascade would appear to reside in the action of the cognate serpins, PAI-1 and PAI-2. How there serpins act biochemically is known, but when and where they act physiologically is undefined. We have recently constructed a unique PAI-resistant uPA by engineering on a surface loop of the uPA molecule a replacement of the serpin binding motif, RRHR. This mutant and selected cells expressing it can be utilized to probe for where and when PAI-I acts to control the uPA/plasmin cascade. The uPA/plasmin cascade also can enhance indirectly the remodeling of tissue matrix by activating other protease cascades, mainly the matrix metalloprotease (MMP) system. We recently have shown that the uPA/plasmin cascade can converge with the activation mechanism of proMMP-9, not directly but through the intermediate action of MMP-3. Whether such cascade convergence can operate in a vascular milieu will be addressed experimentally in the present proposal.
The specific aims of the present proposal are: 1. To identify the Structural Motifs and Sub-sites on pro-uPA that Regulate its Auto-activation Potential and Intrinsic Activity. 2. To examine the Regulatory Role of PAI-I by Utilizing a Mutant Home uPA, huPA/QNIM, Missing the RRHR Serpin Binding Motif. 3. To examine the Functional Link between the uPA/Plasmin Cascade and Activation of Select Matrix Metalloproteases (MMPs).

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL031950-17
Application #
6414463
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
2001-01-01
Project End
2001-12-31
Budget Start
Budget End
Support Year
17
Fiscal Year
2001
Total Cost
$321,374
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Klann, Jane E; Kim, Stephanie H; Remedios, Kelly A et al. (2018) Integrin Activation Controls Regulatory T Cell-Mediated Peripheral Tolerance. J Immunol 200:4012-4023
Griffin, John H; Zlokovic, Berislav V; Mosnier, Laurent O (2018) Activated protein C, protease activated receptor 1, and neuroprotection. Blood 132:159-169
Sinha, Ranjeet K; Wang, Yaoming; Zhao, Zhen et al. (2018) PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke. Blood 131:1163-1171
Xu, Xiaohong Ruby; Wang, Yiming; Adili, Reheman et al. (2018) Apolipoprotein A-IV binds ?IIb?3 integrin and inhibits thrombosis. Nat Commun 9:3608
Gupta, Naveen; Liu, Roland; Shin, Stephanie et al. (2018) SCH79797 improves outcomes in experimental bacterial pneumonia by boosting neutrophil killing and direct antibiotic activity. J Antimicrob Chemother 73:1586-1594
Gupta, Naveen; Sinha, Ranjeet; Krasnodembskaya, Anna et al. (2018) The TLR4-PAR1 Axis Regulates Bone Marrow Mesenchymal Stromal Cell Survival and Therapeutic Capacity in Experimental Bacterial Pneumonia. Stem Cells 36:796-806
Amar, Arun Paul; Sagare, Abhay P; Zhao, Zhen et al. (2018) Can adjunctive therapies augment the efficacy of endovascular thrombolysis? A potential role for activated protein C. Neuropharmacology 134:293-301
Kamikubo, Yuichi; Mendolicchio, G Loredana; Zampolli, Antonella et al. (2017) Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex. Blood 130:1661-1670
Rothmeier, Andrea S; Marchese, Patrizia; Langer, Florian et al. (2017) Tissue Factor Prothrombotic Activity Is Regulated by Integrin-arf6 Trafficking. Arterioscler Thromb Vasc Biol 37:1323-1331
Subramaniam, Saravanan; Jurk, Kerstin; Hobohm, Lukas et al. (2017) Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development. Blood 129:2291-2302

Showing the most recent 10 out of 428 publications